The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC.
An expert response from Dr. James Januzzi.
Dr. Salim Virani reviews the Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes.
An ACC.14 session presentation on Understanding the Universal Definition of MI by Dr. Alan Jaffe.
Drs. Mora, Harada, and Akinkoulie evaluate the pros and cons of standard lipid testing and alternative measures in the context of CVD risk.
A 57-year-old male experiences dyspnea on exertion that began two days prior to admission. The Cardiac Biomarkers editors asked experts in the field to comment on a this case and give their opinion about the most appropriate diagnosis.
Interact and share with your colleagues biomarker topics that are relevant to you and your practice.
Effect of Intravenous TRO40303 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction: MITOCARE Study Results
MicroRNAs as Non-invasive Biomarkers of Heart Transplant Rejection
Twelve–Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke
© 2014 American College of Cardiology Foundation. Visit Cardiosource.
Terms & Conditions
Registered User Agreement
Advertising and Sponsorship Policy